Evolutionary rate covariation is pervasive between glycosylation pathways and points to potential disease modifiers
Preprint in bioRxiv (May 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Removal of pomt1 in zebrafish leads to loss of α-dystroglycan glycosylation and dystroglycanopathy phenotypes
Article in Human Molecular Genetics (January 2024)
Standardization of zebrafish drug testing parameters for muscle diseases
Article in Disease Models & Mechanisms (January 2024)